Vardhaman Laboratories Ltd
Vardhaman Laboratories is engaged in the business of Manufacturing of pharmaceutical products.
- Market Cap ₹ 0.21 Cr.
- Current Price ₹ 0.51
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 4.82
- Dividend Yield 0.00 %
- ROCE -1.99 %
- ROE -1.99 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.11 times its book value
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -1.79% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.41 | 0.28 | 0.31 | 0.27 | 1.24 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | |
| 0.57 | 0.58 | 0.54 | 0.44 | 1.23 | 0.57 | 0.02 | 0.04 | 0.06 | 0.08 | 0.07 | 0.07 | 0.04 | |
| Operating Profit | -0.16 | -0.30 | -0.23 | -0.17 | 0.01 | 0.00 | -0.02 | -0.04 | -0.06 | -0.08 | -0.08 | -0.08 | -0.04 |
| OPM % | -39.02% | -107.14% | -74.19% | -62.96% | 0.81% | 0.00% | |||||||
| 0.02 | 0.24 | 0.08 | 0.02 | 0.01 | 0.29 | -0.01 | 0.02 | 0.03 | 0.05 | 0.04 | 0.04 | 0.01 | |
| Interest | 0.06 | 0.05 | 0.01 | 0.00 | 0.08 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.11 | 0.11 | 0.10 | 0.08 | 0.08 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.31 | -0.22 | -0.26 | -0.23 | -0.14 | 0.27 | -0.04 | -0.02 | -0.03 | -0.03 | -0.04 | -0.04 | -0.03 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 125.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| -0.31 | -0.22 | -0.26 | -0.23 | -0.14 | 0.27 | -0.10 | -0.02 | -0.03 | -0.03 | -0.04 | -0.04 | -0.03 | |
| EPS in Rs | -0.75 | -0.53 | -0.63 | -0.56 | -0.34 | 0.65 | -0.24 | -0.05 | -0.07 | -0.07 | -0.10 | -0.10 | -0.06 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | -13% |
| TTM: | -200% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -2% |
| 3 Years: | -2% |
| Last Year: | -2% |
Balance Sheet
Figures in Rs. Crores
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 |
| Reserves | -1.04 | -1.26 | -1.52 | -2.01 | -2.12 | -1.87 | -1.97 | -1.99 | -2.02 | -2.05 | -2.09 | -2.13 |
| 0.74 | 0.34 | 0.21 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.16 | 0.03 | 0.19 | 0.25 | 1.12 | 0.00 | 0.02 | 0.01 | 0.01 | 0.03 | 0.02 | 0.04 | |
| Total Liabilities | 3.98 | 3.23 | 3.00 | 2.60 | 3.12 | 2.25 | 2.17 | 2.14 | 2.11 | 2.10 | 2.05 | 2.03 |
| 2.29 | 2.19 | 2.09 | 1.63 | 1.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.37 | 0.06 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 1.32 | 0.98 | 0.87 | 0.93 | 1.53 | 2.25 | 2.17 | 2.14 | 2.11 | 2.10 | 2.05 | 2.03 | |
| Total Assets | 3.98 | 3.23 | 3.00 | 2.60 | 3.12 | 2.25 | 2.17 | 2.14 | 2.11 | 2.10 | 2.05 | 2.03 |
Cash Flows
Figures in Rs. Crores
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.08 | 0.01 | 0.01 | -0.12 | 0.41 | -1.75 | -0.06 | 0.12 | 0.31 | 0.00 | -0.04 | 0.02 | |
| -0.05 | 0.43 | 0.02 | 0.00 | 0.07 | 1.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.13 | -0.44 | -0.03 | 0.15 | -0.32 | -0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.03 | 0.16 | -0.03 | -0.06 | 0.12 | 0.31 | 0.00 | -0.04 | 0.02 |
| Free Cash Flow | -0.38 | 0.00 | 0.01 | -0.12 | 0.38 | -0.21 | -0.06 | 0.12 | 0.31 | 0.00 | -0.04 | 0.02 |
| CFO/OP | 50% | -3% | -4% | 71% | 4,100% | 50% | -300% | -517% | 0% | 50% | -25% |
Ratios
Figures in Rs. Crores
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 462.93 | 495.36 | 259.03 | 270.37 | 332.62 | 1,331.93 | -56,940.00 | -56,940.00 | ||||
| Inventory Days | 812.95 | 1,460.00 | 919.80 | 1,460.00 | 65.05 | 0.00 | 0.00 | 0.00 | ||||
| Days Payable | 265.45 | 73.00 | 102.20 | 279.12 | 350.54 | |||||||
| Cash Conversion Cycle | 1,010.43 | 1,882.36 | 1,076.63 | 1,451.25 | 47.13 | 1,331.93 | -56,940.00 | -56,940.00 | ||||
| Working Capital Days | 1,023.78 | 1,238.39 | 918.39 | 1,013.89 | 97.14 | 1,331.93 | 56,940.00 | 57,305.00 | ||||
| ROCE % | -6.44% | -7.98% | -8.32% | -8.91% | -2.76% | -0.94% | -0.45% | -0.93% | -1.42% | -1.44% | -1.95% | -1.99% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Feb 2019
- Outcome of Board Meeting 19 Feb 2019
- Board Meeting Intimation for Intimation Of Board Meeting For The Quarter Ended 31St December, 2018. 8 Feb 2019
- Shareholding for the Period Ended December 31, 2018 21 Jan 2019
-
Statement Of Investor Complaints For The Quarter Ended December 2018
21 Jan 2019 - No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter …